Literature DB >> 9073034

The apolipoprotein E epsilon4 allele causes a faster decline of cognitive performances in Down's syndrome subjects.

R Del Bo1, G P Comi, N Bresolin, E Castelli, E Conti, A Degiuli, C D Ausenda, G Scarlato.   

Abstract

The apolipoprotein E gene (APOE), located on human chromosome 19, has three common alleles (epsilon2, epsilon3, epsilon4) which encode for the three main isoforms indicated as E2, E3 and E4 respectively. Several findings indicate epsilon4 allele as an important risk factor in both sporadic and familial late-onset Alzheimer's disease (AD). Pathological changes similar to AD are seen in almost all patients with Down's syndrome (DS) aged over 35 (senile plaques, neurofibrillary tangles and neuronal loss); a proportion of these may subsequently develop dementia. Aim of this study is to evaluate the possible pathological role of epsilon4 allele as risk factor for developing AD in a DS population. ApoE epsilon4 allele frequency is not significantly different in DS cases and controls. We found a statistically significant inverse correlation between full scale IQ values and age of patients in the subgroup of DS subjects selected for the presence of at least one epsilon4 allele, while no correlation was observed in DS subjects with other ApoE genotypes. A longitudinal analysis of cognitive performances (available in 38 patients) showed a faster rate of decline in intellectual ability in those subjects carrying at least one epsilon4 allele. Our data support the hypothesis that ApoE epsilon4 allele has a contributory role in accelerating the mental deterioration of AD-type in DS patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9073034     DOI: 10.1016/s0022-510x(96)00249-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

1.  Alzheimer's Disease in Adults with Down Syndrome.

Authors:  Warren B Zigman; Darlynne A Devenny; Sharon J Krinsky-McHale; Edmund C Jenkins; Tiina K Urv; Jerzy Wegiel; Nicole Schupf; Wayne Silverman
Journal:  Int Rev Res Ment Retard       Date:  2008-01-01

2.  Genetic effect of MTHFR C677T polymorphism on the structural covariance network and white-matter integrity in Alzheimer's disease.

Authors:  Yu-Tzu Chang; Shih-Wei Hsu; Shih-Jen Tsai; Ya-Ting Chang; Chi-Wei Huang; Mu-En Liu; Nai-Ching Chen; Wen-Neng Chang; Jung-Lung Hsu; Chen-Chang Lee; Chiung-Chih Chang
Journal:  Hum Brain Mapp       Date:  2017-03-25       Impact factor: 5.038

3.  APOE ε2 and ε4 influence the susceptibility for Alzheimer's disease but not other dementias.

Authors:  Carlo Lovati; Daniela Galimberti; Diego Albani; Pierluigi Bertora; Eliana Venturelli; Giuliana Cislaghi; Ilaria Guidi; Chiara Fenoglio; Francesca Cortini; Francesca Clerici; Dario Finazzi; Gianluigi Forloni; Elio Scarpini; Claudio Mariani
Journal:  Int J Mol Epidemiol Genet       Date:  2010-04-05

4.  Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides.

Authors:  M H Baumann; J Kallijärvi; H Lankinen; C Soto; M Haltia
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

5.  Impairments in spatial memory retention of GFAP-apoE4 female mice.

Authors:  Peter van Meer; Summer Acevedo; Jacob Raber
Journal:  Behav Brain Res       Date:  2006-11-28       Impact factor: 3.332

6.  Candidate gene analysis of semaphorins in patients with Alzheimer's disease.

Authors:  Chiara Villa; Eliana Venturelli; Chiara Fenoglio; Milena De Riz; Diego Scalabrini; Francesca Cortini; Maria Serpente; Claudia Cantoni; Nereo Bresolin; Elio Scarpini; Daniela Galimberti
Journal:  Neurol Sci       Date:  2009-12-03       Impact factor: 3.307

7.  Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.

Authors:  Chiara Fenoglio; Daniela Galimberti; Francesca Cortini; John S K Kauwe; Carlos Cruchaga; Eliana Venturelli; Chiara Villa; Maria Serpente; Diego Scalabrini; Kevin Mayo; Laura M Piccio; Francesca Clerici; Diego Albani; Claudio Mariani; Gianluigi Forloni; Nereo Bresolin; Alison M Goate; Elio Scarpini
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 8.  AR, apoE, and cognitive function.

Authors:  Jacob Raber
Journal:  Horm Behav       Date:  2008-02-26       Impact factor: 3.587

9.  Age-related changes of adaptive and neuropsychological features in persons with Down Syndrome.

Authors:  Alessandro Ghezzo; Stefano Salvioli; Maria Caterina Solimando; Alice Palmieri; Chiara Chiostergi; Maria Scurti; Laura Lomartire; Federica Bedetti; Guido Cocchi; Daniela Follo; Emanuela Pipitone; Paolo Rovatti; Jessica Zamberletti; Tiziano Gomiero; Gastone Castellani; Claudio Franceschi
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

10.  Clinical Significance of Cerebrovascular Biomarkers and White Matter Tract Integrity in Alzheimer Disease: Clinical correlations With Neurobehavioral Data in Cross-Sectional and After 18 Months Follow-ups.

Authors:  Ming-Kung Wu; Yan-Ting Lu; Chi-Wei Huang; Pin-Hsuan Lin; Nai-Ching Chen; Chun-Chung Lui; Wen-Neng Chang; Chen-Chang Lee; Ya-Ting Chang; Sz-Fan Chen; Chiung-Chih Chang
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.